The growing field of precision medicine holds incredible promise for delivering better patient care and medical innovation, but there are barriers to greater implementation. As an emerging approach for disease treatment and prevention, precision medicine takes into account individual variability in genes, environment and lifestyle for each person. Its implementation has primarily been hastened by reducing sequencing costs.
81% of marketers say content is a core business strategy. Yet, if you ask them how their content marketing strategy is working out, you will hear varying answers. Hmm, why is that? Well, the approaches in content marketing change so quickly that it’s hard to choose a perfect tactic. Even so, content is the best tool to boost your conversions and reach sustainable business growth. You may struggle to outrank the competitors in the market even though you are putting in their best efforts.
When it comes to monetizing APIs, there are a lot of ways you can do it. One popular way to do so is to charge based on how many unique users are utilizing your API. A good example would be charging $7 per month for each user using your API. For a company with five users accessing the API in a given month, their monthly statement would show a charge of $35 (plus any applicable taxes).
In a previous blog post (How To Survive an Apache Kafka® Outage) I outlined the effects on applications during partial or total Kafka cluster outages and proposed some architectural strategies to handle these types of service interruptions. The applications most heavily impacted by this type of outage are external interfaces that receive data, do not control request flow, and possibly perform some form of business transaction with the outside world before producing to Kafka.
The past year has seen an unprecedented AI hype wave triggered by the launch of OpenAI’s ChatGPT. Analysis abounds on whether the hype is real, where value will accrue and whether generative AI-first product builders have a real shot at category disruption or creation. As frenzied R&D and market activity continue unabated, market maps and take after take continue to drop hot. But what about revenue?
